Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections.
about
Urinary tract infections: epidemiology, mechanisms of infection and treatment optionsModulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans ModelComparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients: an analysis of national representative claims databaseDevelopment of a panel of recombinase polymerase amplification assays for detection of common bacterial urinary tract infection pathogens.Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract InfectionsAntimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013.Molecular Characterisation of nfsA Gene in Nitrofurantoin Resistant Uropathogens.Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more.AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.Genetic Variability of AdeRS Two-Component System Associated with Tigecycline Resistance in XDR-Acinetobacter baumannii Isolates.Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.Local drug delivery in the urinary tract: current challenges and opportunities.
P2860
Q27022487-8959A2E0-AB69-4401-9626-2AB2D727BB0FQ30385057-FE969C92-6341-41E9-9F68-08B22704E602Q36153920-BA9E7A44-DDCA-4414-B7F5-A04C1EBE1222Q36373340-4C3D9252-4514-4D83-A844-8B7D7591EB04Q36683599-C7D151B0-B046-48CA-855B-30284CF40873Q37119884-BE1E92BF-B51D-4A8E-B291-13F0A321117FQ37132442-F01DC97C-5C71-43CC-A9C3-369760F05FEEQ38267242-0FF9C770-7337-43C5-9AEC-B64155947943Q38385964-1FF2DB6B-830A-4956-BD38-18489FEFC9C7Q39905753-32578E87-B6F3-412A-8035-671B6357E6E0Q40976615-8885A7D4-D2C8-40C2-B95F-4E34ABBAF11EQ41281692-2F9901B2-8811-41CB-94D8-CE1A4943C5D0Q49685896-77478C08-E634-4DCC-BDDA-2021B67D8E83
P2860
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging resistance problems a ...... ated urinary tract infections.
@en
type
label
Emerging resistance problems a ...... ated urinary tract infections.
@en
prefLabel
Emerging resistance problems a ...... ated urinary tract infections.
@en
P2860
P1476
Emerging resistance problems a ...... ated urinary tract infections.
@en
P2093
Wen-Chien Ko
Yen-Hsu Chen
P2860
P304
P356
10.1517/14656566.2013.778827
P407
P50
P577
2013-04-01T00:00:00Z